Assessment of the white-coat effect
Journal of Hypertension2005Vol. 24(1), pp. 67–74
Citations Over TimeTop 10% of 2005 papers
William Gerin, Gbenga Ogedegbe, Joseph E. Schwartz, William F. Chaplin, Tanya Goyal, Lynn Clemow, Karina W. Davidson, Matthew M. Burg, Shira I. Lipsky, Rebecca Kentor, Juhee Jhalani, Daichi Shimbo, Thomas G. Pickering
Abstract
The WCE may not just be limited to that narrow interval in which the patient actually sees the physician, but may generalize to the clinic setting, rendering a clinic 'resting' level invalid. While it is strongly positive in most hypertensive patients, it is frequently negative in normotensive patients. Our results suggest that improved methods of measuring blood pressure in the clinic setting are unlikely to resolve the confounding influence of the WCE, and that greater reliance will need to be placed on out-of-office monitoring.
Related Papers
- → Ambulatory Blood Pressure Monitoring in Clinical Practice: A Review(2014)121 cited
- → Prognosis of “Masked” Hypertension and “White-Coat” Hypertension Detected by 24-h Ambulatory Blood Pressure Monitoring. 10-Year Follow-up From the Ohasama Study(2005)54 cited
- → Ambulatory blood pressure monitoring should be included in the National Health and Nutritional Examination Survey (NHANES)(2012)7 cited
- [White-coat hypertension].(2014)
- [Prognostic importance of white coat and masked hypertension].(2009)